Date de publication: 18 mars 2024
Promoteur – Intermédiaire Financier
RESOLVE BIOSCIENCES BVLieu
Description
The project supports the promoter's activities related to research, development (R&D), regulatory requirements, and commercialisation, as well as IPs of its innovative High Resolution Pathology technology.
Objectifs
The aim is to support the R&D activities of the Promoter, including IP, regulatory and other investments related to the development of its technology based on spatial biology, as well as the market entry of its innovative products in a clinical use and drug development context.
Secteur(s)
- Industrie - Industrie manufacturière
Montant BEI envisagé (montant approximatif)
EUR 30 million
Coût total (montant approximatif)
EUR 70 million
Aspects environnementaux
The concerned R&D activities are expected to be carried out in the Promoter's existing facilities or other research centers already authorised for the same purpose and would therefore not require an environmental impact assessment (EIA) under the Directive 2014/52/EU amending the EIA Directive 2011/92/EU. Full environmental details will be verified during the appraisal by the EIB for compliance of the project with the relevant European legislation.
Passation des marchés
The Bank will require that all project contracts are procured in accordance with the applicable EU procurement legislation.
Statut
À l'examen
Clause de non-responsabilité
Avant d’être approuvés par le Conseil d’administration et avant la signature des prêts correspondants, les projets font l’objet d’une instruction et de négociations. Par conséquent, les informations et données fournies sur cette page sont indicatives.
Elles sont fournies à des fins de transparence uniquement et ne peuvent être considérées comme représentant la politique officielle de la BEI (voir également les notes explicatives).